Volume 42, Issue 4 p. iii
ADDITIONAL COVER
Open Access

Cover Image, Volume 42, Issue 4

Xiao-Dong ZhuMing-Zhu HuangYu-Sheng WangWan-Jing FengZhi-Yu ChenYi-Fu HeXiao-Wei ZhangXin LiuChen-Chen WangWen ZhangJie-Er YingJun WuLei YangYan-Ru QinJian-Feng LuoXiao-Ying ZhaoWen-Hua LiZhe ZhangLi-Xin QiuQi-Rong GengJian-Ling ZouJie-Yun ZhangHong ZhengXue-Feng SongShu-Sheng WuCheng-Yan ZhangZhe GongQin-Qin LiuXiao-Feng WangQi XuQi WangJian-Mei JiJian ZhaoWei-Jian Guo
First published: 19 April 2022

Graphical Abstract

The cover image is based on the Original Article XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX) by Wei-Jian Guo et al., https://doi.org/10.1002/cac2.12278.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.